Sign in to continue:

Monday, March 2nd, 2026

Progen Holdings Ltd 2025 Financial Results – Revenue Decline, No Dividend Declared

Progen Holdings Ltd: FY2025 Financial Analysis and Investment Insights

Progen Holdings Ltd, listed on the Catalist Board of SGX, has released its unaudited condensed interim financial statements for the six months and full year ended 31 December 2025. Below is a comprehensive review and analysis of the company’s financial performance, business outlook, and recommendations for investors.

Key Financial Metrics and Comparative Performance

Metric 2H FY2025
(6 months)
1H FY2025
(6 months)
2H FY2024
(6 months)
YoY Change QoQ Change
Revenue \$3,024k \$2,038k \$4,172k -27.5% +48.4%
Operating Profit/(Loss) After Tax \$77k \$(770)k \$274k -71.9% +110.0%
EPS (cents, basic) 0.020 -0.197 0.070 -71.4% +110.0%
Dividend per share Nil Nil Nil No Change No Change
Metric FY2025
(12 months)
FY2024
(12 months)
YoY Change
Total Revenue \$5,062k \$5,698k -11.2%
Net Profit/(Loss) After Tax \$(693)k \$(720)k -3.8%
EPS (cents, basic) -0.177 -0.184 +3.8%
Dividend per share Nil Nil No Change
Net Asset Value per share (cents) 6.40 6.57 -2.6%

Historical Performance Trends and Segment Review

  • Revenue: The Group saw an 11.2% YoY decline in revenue, primarily driven by lower contributions from the Products and installation segment. This segment’s revenue fell by 16.7%, attributed to a major project nearing completion and slower ramp-up of new projects. Rental income grew by 15.9% thanks to higher occupancy, while servicing and maintenance was up 8.9%.
  • Profitability: The Group remained loss-making, but the net loss narrowed slightly to \$693k from \$720k. The second half of FY2025 saw a much smaller loss, with an operating profit after tax of \$77k, indicating some recovery compared to the first half and the previous year’s second half.
  • Other Income: Other income more than halved due to the absence of profit from associated companies, lower interest income, and reduced fair value gains and dividends.
  • Cost Management: Costs of Products and installation dropped by 34.6%, closely tracking the reduction in segment revenue. Property operating expenses also decreased due to the absence of one-off repairs. Salaries, depreciation, other expenses, and finance costs stayed relatively constant.
  • Asset Movements: The Group’s investment in an associated company dropped due to recognized losses. Investments in debt instruments increased, but there was a fair value loss. Trade receivables declined in line with lower sales, while contract assets rose due to project timing.

Exceptional Items and Notable Events

  • Share of Loss from Associated Company: FY2025 records a loss of \$85k from the associated company compared to a gain of \$102k in FY2024.
  • Asset Revaluation: Investments in unquoted debt instruments are marked to fair value, resulting in a fair value loss of \$27k for FY2025.
  • No Dividends: No interim or final dividends were declared for FY2025 or FY2024 due to ongoing losses.
  • No Share Buybacks, Placements, or Fundraising: The company’s share capital remained unchanged, and there were no treasury shares, placements, or fundraising activities.

Cash Flow Insights

  • Cash and Cash Equivalents: The Group’s net cash and cash equivalents decreased by \$337k in FY2025, mainly due to negative operating cash flow, additional investment in debt instruments, and lease payments.
  • Net Asset Value: Net asset value per share declined from 6.57 cents to 6.40 cents, reflecting the continued losses and asset movements.

Business Outlook

The Board’s outlook for the next 12 months remains cautious:

“The outlook for the next 12 months remains challenging amidst vast uncertainties in domestic and global market conditions.
The Group will continue to explore new business opportunities, transform and consolidate its existing businesses to improve effectiveness and efficiency, and synergise and optimise resources across its businesses.”

The tone is defensive and realistic, acknowledging headwinds and uncertainties while emphasizing ongoing efforts to optimize and seek new growth areas.

Other Noteworthy Disclosures

  • Related Party Transactions: No interested person transactions or related party fund flows were reported.
  • Corporate Actions: No new acquisitions, divestments, asset sales, or IPOs were undertaken in FY2025.
  • Directors’ Remuneration: No specific figures disclosed, but two managerial positions are held by family members of the Managing Director, with no changes in their roles.
  • Subsequent Events: No significant events reported after the balance sheet date.
  • Taxation: Deferred tax asset unrecognized due to uncertainty of recoverability.

Conclusion and Investment Recommendations

Overall, Progen Holdings Ltd’s FY2025 performance remains weak, evidenced by continued losses, declining revenue, and lack of dividend distribution. The second half of the year showed some improvement in operating profit, but the outlook remains cautious due to macroeconomic uncertainties and slow project ramp-ups. The company is focusing on efficiency and new business opportunities, but it has yet to return to sustainable profitability.

Investor Recommendations:

  • If you are currently holding the stock: Consider maintaining a cautious stance. Monitor for signs of operational turnaround and improved profitability. The absence of dividends and the continued losses are negatives, but the company’s focus on transformation and resource optimization could yield results if market conditions improve.
  • If you are not holding the stock: It may be prudent to wait for clearer evidence of sustainable profitability and revenue growth before considering an entry. The current weak performance and uncertain outlook do not justify aggressive buying, especially given the lack of dividends and macro risks.

Disclaimer: This analysis is based solely on information disclosed in the company’s financial report and does not constitute financial advice. Investors should conduct their own due diligence before making any investment decisions.

View Progen Historical chart here



Pasture Holdings Ltd FY2024 – From Loss to Profit with Strong Growth in Healthcare and Pet Markets

Business Overview Core Business Operations: Pasture Holdings Ltd. is a global pharmaceutical and medical supply company, offering products across three primary segments: Masks: Pasture Masks™, developed in collaboration with contract manufacturers, have garnered trust...

Nanofilm Technologies 1H2025 Results: 30% Revenue Growth, S$95m Cash Balance, Interim Dividend of 0.33₵ per Share Announced 6

Nanofilm Technologies International 1H2025 Financial Results Analysis Nanofilm Technologies International has announced its results for the first half of 2025, showing a marked improvement in financial performance across all business units and a return...

Pacific Radiance Ltd 6M 2025 Financial Results: Revenue Up 28%, No Interim Dividend Declared

Pacific Radiance Ltd. 1H 2025 Financial Results: Strong Operational Recovery Amid Market Headwinds Pacific Radiance Ltd., listed on the SGX, has released its condensed interim financial statements for the six months ended 30 June...

   Ad